Table 3 shows the characteristics of the changes in LN-5, FN, and COL IV concentrations depending on the grade of the disease and other data available in the clinical description of the samples: tumour size, presence of other cancers in the patient’s immediate family, and presence of comorbidities in the patient. This evidence concerns the gene FN1 and neoplasm.